Open Forum Infect Dis . Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic

[tetano]

Open Forum Infect Dis


. 2021 Mar 26;8(7):ofab151.
doi: 10.1093/ofid/ofab151. eCollection 2021 Jul.
Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic


J Ryan Bariola ¹ , Erin K McCreary ¹ , Tina Khadem ¹ , Graham M Snyder ¹ , Richard J Wadas ² , David A Nace ³ , Douglas B White ⁴ , Donald M Yealy ² , Mark Schmidhofer ⁵



Affiliations

• PMID: 34322560
• PMCID: PMC8083628
• DOI: 10.1093/ofid/ofab151

Abstract

Emergency authorized coronavirus disease 2019 (COVID-19)-neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons learned.

Keywords: COVID-19; COVID-19 therapies; monoclonal antibodies.